Evidence map›Paper›PMID 33262574›Full record

ArticleDrug design, development and therapy2020

Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.

Peng-Fei Tang, Xiang Zheng, Xiao-Xia Hu, Cheng-Cheng Yang, Zhe Chen, Jian-Chang Qian, Jian-Ping Cai, Guo-Xin Hu

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Genomewide Association Study of Simvastatin Pharmacokinetics.Clinical pharmacology and therapeutics · 2022
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Pharmacokinetic profile of sildenafil citrate in healthy Middle Eastern Males: Comparison with other ethnicities.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Peng-Fei Tang *Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, People's Republic of China.
Xiang Zheng *Dong Yang People's Hospital, Jinhua, Zhejiang 322100, People's Republic of China.
Xiao-Xia HuAffiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang 321000, People's Republic of China.ORCID 0000-0002-8807-5036
Cheng-Cheng YangNingbo First Hospital, Ningbo 315010, Zhejiang, People's Republic of China.ORCID 0000-0002-4169-7161
Zhe ChenWenzhou People's Hospital, Wenzhou, Zhejiang 325000, People's Republic of China.ORCID 0000-0003-3105-3589
Jian-Chang QianSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325000, Zhejiang, People's Republic of China.
Jian-Ping CaiThe Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics, Ministry of Health, Beijing 100730, People's Republic of China.ORCID 0000-0003-2793-9221
Guo-Xin HuAffiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, People's Republic of China.
Wenzhou Medical University · CNBeijing Hospital · CNNingbo First Hospital · CNWenzhou City People's Hospital · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe aimed to systematically examine the effects of enzymatic activity of 38 human

methodsThe recombinant cytochrome P450 alleles protein of

resultsThe intrinsic clearance (Vmax/Km) values of most

conclusionThese findings were the first evaluation of all these infrequent

Indexed as

AllelesCytochrome P-450 CYP2C9Cytochrome P-450 CYP3AHumansPolymorphism, GeneticRecombinant ProteinsSildenafil CitrateCYP2C9 protein, humanCYP3A4 protein, humanCytochrome P-450 CYP2C9Cytochrome P-450 CYP3ARecombinant ProteinsSildenafil Citrateallelic variantsCYP2C9 polymorphismsCYP3A4 polymorphismsenzymatic activityindividual treatmentsildenafil

Identifiers

PMID33262574
PMCPMC7699448
OpenAlexW3108287772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.